Two Sigma Advisers’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.3K | Sell |
66,300
-174,600
| -72% | -$125K | ﹤0.01% | 2258 |
|
|
2025
Q1 | $157K | Sell |
240,900
-306,900
| -56% | -$200K | ﹤0.01% | 2178 |
|
|
2024
Q4 | $1.01M | Sell |
547,800
-43,100
| -7% | -$79.3K | ﹤0.01% | 1457 |
|
|
2024
Q3 | $2.04M | Sell |
590,900
-95,600
| -14% | -$331K | ﹤0.01% | 1048 |
|
|
2024
Q2 | $2.01M | Buy |
686,500
+15,400
| +2% | +$45.1K | ﹤0.01% | 1190 |
|
|
2024
Q1 | $3.79M | Buy |
671,100
+431,300
| +180% | +$2.44M | 0.01% | 900 |
|
|
2023
Q4 | $1.03M | Buy |
239,800
+54,600
| +29% | +$234K | ﹤0.01% | 1638 |
|
|
2023
Q3 | $643K | Sell |
185,200
-164,500
| -47% | -$571K | ﹤0.01% | 1700 |
|
|
2023
Q2 | $1.63M | Sell |
349,700
-71,600
| -17% | -$333K | ﹤0.01% | 1303 |
|
|
2023
Q1 | $1.95M | Buy |
421,300
+38,200
| +10% | +$176K | 0.01% | 1283 |
|
|
2022
Q4 | $3.1M | Buy |
383,100
+35,600
| +10% | +$288K | 0.01% | 999 |
|
|
2022
Q3 | $1.93M | Buy |
347,500
+87,000
| +33% | +$483K | 0.01% | 1188 |
|
|
2022
Q2 | $1.36M | Buy |
260,500
+153,600
| +144% | +$800K | ﹤0.01% | 1429 |
|
|
2022
Q1 | $879K | Buy |
106,900
+12,600
| +13% | +$104K | ﹤0.01% | 1700 |
|
|
2021
Q4 | $1.4M | Sell |
94,300
-60,000
| -39% | -$893K | ﹤0.01% | 1369 |
|
|
2021
Q3 | $2.92M | Buy |
154,300
+62,300
| +68% | +$1.18M | 0.01% | 1056 |
|
|
2021
Q2 | $1.71M | Buy |
92,000
+32,200
| +54% | +$599K | ﹤0.01% | 1368 |
|
|
2021
Q1 | $1.36M | Buy |
59,800
+16,900
| +39% | +$385K | ﹤0.01% | 1474 |
|
|
2020
Q4 | $931K | Buy |
42,900
+1,100
| +3% | +$23.9K | ﹤0.01% | 1594 |
|
|
2020
Q3 | $420K | Buy |
+41,800
| New | +$420K | ﹤0.01% | 1886 |
|